🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will characterize the pharmacokinetics (PK) of certolizumab pego...
Status
Completed
Location
1
Start Date
2015-03
Trial ID
NCT02365948
Treatments Being Tested
The purpose of the study is to assess systemic certolizumab pegol (CZP) exp...
Status
Completed
Location
Up0085 104
Start Date
2020-06-19
Trial ID
NCT04163016
Treatments Being Tested
A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and ...
Status
Completed
Location
Ra0043 71
Start Date
2012-03-08
Trial ID
NCT01550003
Treatments Being Tested
The objectives of this study are to verify the superiority in efficacy (Ame...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00791921
Treatments Being Tested
The objective of this trial is to investigate the efficacy (American Colleg...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00791999
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The purpose of the study is to evaluate the pharmacokinetics and safety of ...
Status
Completed
Location
Ra0138 1009
Start Date
2021-02-11
Trial ID
NCT04740814
Treatments Being Tested
The purpose of the study is to assess efficacy, safety and tolerability of ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-06
Trial ID
NCT04643483
Treatments Being Tested
The purpose of the study is to evaluate the pharmacokinetic (PK) of certoli...
Status
Completed
Location
Ps0007 50175
Start Date
2020-01-21
Trial ID
NCT04123795
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy and body dist...
Status
Completed
Location
Ra0123 101
Start Date
2015-04
Trial ID
NCT02430909
Treatments Being Tested